October 14, 2025

What Happened at Meeting on the Mesa 2025?

This year’s Meeting on the Mesa showed that cell and gene therapy is no longer defined by hype, but by hard work– from digital manufacturing to creative funding models and policy alignment.

The Medicine Maker

October 10, 2025

Adolescent and Adult VTE After Arthroscopy Compared in Study

Lower venous thromboembolism risk is shown in adolescents than adults after knee arthroscopy, but comorbidities like diabetes and obesity raise risk.

Conexiant

October 07, 2025

FDA Announces New Development in Lung Care

The FDA has approved the first treatment in more than a decade for idiopathic pulmonary fibrosis.

Conexiant

October 07, 2025

Sotatercept Reduced Clinical Worsening in PAH

Kaplan-Meier curves indicated a clinical benefit after three doses.

Conexiant

October 06, 2025

Sarcopenia Prevalence Reported in Advanced Lung Disease, Study

Researchers evaluate sarcopenia definitions and tools in patients with lung disease.

Conexiant

October 02, 2025

Distal vs Shaft Tibia Fractures in Children

Open distal tibia fractures in pediatric patients are more severe than shaft fractures.

Conexiant

September 26, 2025

FDA Approves First Once-Daily Oral Therapy for Acromegaly

Once-daily paltusotine offers an oral alternative to monthly injections for eligible adults.

Conexiant

September 25, 2025

CT-Detected Emphysema Predicted COPD Mortality

Severe emphysema increased COPD death risk more than 12-fold in lung screening cohort.

Conexiant

September 23, 2025

Juvenile SLE: Feasibility of Early Glucocorticoid Tapering

Early glucocorticoid tapering in juvenile systemic lupus erythematosus is feasible without added flare risk, though anti-double-stranded DNA positivity signals higher relapse odds.

Conexiant